比瓜尼德通过剂量依赖的线粒体重编程驱动的c-Src通路对抗调节瘤特性
Jun Hyoung Park1, Kwang Hwa Jung1, Dongya Jia2
1Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA.
Cell reports. Medicine
|February 11, 2025
概括
一种抗癌药物梅特福明可能通过激活脂肪酸氧化 (FAO) 和Src信号在一些患者中,意外地促进乳腺癌的生长. 抑制FAO或使用Src抑制剂与甲胺一起显示出治疗侵袭性三阴性乳腺癌的前景.
科学领域:
- 在瘤学瘤学.
- 代谢途径 代谢途径
- 癌症信号传递 癌症信号传递
背景情况:
- 甲胺是一种比古安化物,通过减弱线粒体氧化,研究其抗癌性质.
- 临床研究表明,在一小部分乳腺癌 (BC) 患者中,甲福明可能会增加乳腺增殖和脂肪酸β-氧化 (FAO).
- 粮农组织对Src酶的激活与侵袭性三阴性乳腺癌 (TNBC) 有关.
研究的目的:
- 调查低剂量比古安化物驱动信号 (AMPK-ACC-FAO) 激活TNBC中的Src通路的假设.
- 在TNBC模型中探索大化物,FAO抑制和Src抑制剂的协同效应.
主要方法:
- 利用TNBC异种移植模型模拟低剂量甲福林的效果,因为其生物利用率低.
- 评估了粮农组织药理和遗传抑制对比瓜尼德疗效的影响.
- 评估了甲福明和达沙替尼 (一种SRC抑制剂) 对TNBC生长和转移的联合作用.
- 研究了高脂肪饮食对组合疗法的疗效的影响.
主要成果:
- 粮农组织的药理或遗传抑制显著增强了比瓜尼德的抗瘤作用.
- 发现较低剂量的比瓜尼德可诱导Src信号传递,而较高剂量则可以抑制它.
- 甲胺和达沙替尼布证明了TNBC患者衍生的异种移植生长的协同抑制,这种效应在高脂肪饮食养的小鼠中没有观察到.
- 组合疗法也抑制了TNBC转移性进展.
结论:
- 低剂量比瓜尼德驱动的粮农组织信号可以激活TNBC中的Src通路,可能抵消抗瘤效应.
- 抑制FAO或将大化物与Src抑制剂结合起来,为向转移性TNBC提供了一种协同策略.
- 这种组合疗法为治疗TNBC提供了有前途的方法,特别是在选择有限的患者中.
更多相关视频
11:13Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
Published on: June 9, 2023
1.5K
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012
18.7K
相关概念视频
03:03mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
02:34Inhibition of Cdk Activity
4.6K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.6K
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
02:38Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
01:26Oral Hypoglycemic Agents: Biguanides and Glitazones
160
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
160
02:23Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K